Philippines gives FDA emergency use powers for Covid-19 drugs, vaccines


The Philippines is racing to lock in vaccine supplies as it targets to immunise a third of it 108 million population. - Reuters

MANILA (Reuters/Xinhua): Philippines President Rodrigo Duterte issued an executive order on Wednesday (Dec 2) granting the Food and Drug Administration (FDA) the power to clear Covid-19 drugs and vaccine for emergency use.

The Philippines wants to start immunising 25 million people next year against the coronavirus, hoping to restore some normalcy after nearly nine months of at times harsh restrictions, and prevent the economy from sinking deeper into recession.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Philippines , FDA , covid-19 , vaccines , drugs

   

Next In Aseanplus News

Malaysian singer Shila Amzah welcomes baby daughter with husband Ubai
TikTok and China’s ByteDance sue to block US law seeking sale or ban of app
Hong Kong MTR plans unprecedented service suspensions on two lines for up to 2 days in row for upgrades
Incoming Taiwan leader is open to Beijing dialogue ‘on equal footing’ with ‘mutual respect’: envoy
Meituan’s KeeTa app leads Hong Kong’s food delivery market by order volume in March quarter, surpassing rival Foodpanda
‘The worst seems over’ for ‘cheap’ and ‘reasonably attractive’ Chinese stocks: EFG Asset Management
Struggling Hong Kong bars hope lucky draw will provide shot in arm but Lan Kwai Fong’s Allan Zeman urges them to look beyond ‘desperate’ measures
Xi Jinping banking on Hungary and Serbia in face of growing China-Europe tensions
Cathay Pacific’s HK Express to charge fliers for carry-on suitcase option under new baggage policy
China’s overcapacity dilemma solvable with ‘painful’ industrial revamp, scholars say

Others Also Read